1. Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Toulouse, France;
2. L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, France;
3. Mayo Clinic, Scottsdale, AZ;
4. John Theurer Cancer Center at Hackensack University, Hackensack, NJ;
5. National and Kapodistrian University of Athens, Athens, Greece;
6. Department of Internal Medicine, University Hospital, Praha, Czech Republic;
7. St. István and St. Laszlo Hospital, Budapest, Hungary;
8. University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
9. Hospital Clínic de Barcelona, Barcelona, Spain;
10. Hematology Clinic University Multiprofile Hospital for Active Treatment “Sv. Georgi” and Medical University, Plovdiv, Bulgaria;
11. Queen Joanna University Hospital, Sofia, Bulgaria;
12. Charles University Faculty Hospital and Faculty of Medicine, Hradec Králové, Czech Republic;
13. University Hospital of Salamanca/Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain;
14. The University of Texas MD Anderson Cancer Center, Houston, TX;
15. Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY;
16. Institut Català d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain;
17. University of Chicago Medical Center, Chicago, IL;
18. Department of Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic;
19. University of Torino, Torino, Italy;
20. Fred Hutchinson Cancer Research Center, Seattle, WA;
21. Princess Margaret Cancer Centre, Toronto, ON, Canada;
22. Hadassah-Hebrew University Medical Center, Jerusalem, Israel;
23. Onyx Pharmaceuticals Inc., South San Francisco, CA; and
24. University of Nantes, Nantes, France